Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
Maximilian Burger(University of Regensburg), Ellen C. Zwarthoff(Erasmus MC), Peter J. Wild(Goethe University Frankfurt), Wolf F. Wieland(University of Regensburg), Arndt Hartmann(Universitätsklinikum Erlangen), Johanna M.M. van Oers(Erasmus MC), Theodorus van der Kwast(Erasmus MC), Anke Brinkmann(University of Regensburg), Stefan Denzinger(University of Regensburg), Madelon N.M. van der Aa(Erasmus MC), Ferdinand Hofstaedter(University of Regensburg), Wim J. Kirkels(Erasmus MC), Robert Stoehr(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 178
Related Papers
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
|Nature Methods|2014|2k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654